{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:29Z","timestamp":1786121369093,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106160","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:08:28Z","timestamp":1778911708000},"page":"106160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of Combined Progression Index (CPI) in 132 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy"],"prefix":"10.1016","volume":"175","author":[{"given":"Magnus Skov","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Patrick","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Wilki","family":"Fristrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Bau","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Graversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-2333","authenticated-orcid":false,"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106160_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/pp-2021-0154","article-title":"A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Li","year":"2022","journal-title":"Pleura and Peritoneum"},{"key":"10.1016\/j.humpath.2026.106160_bib2","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010034","article-title":"Overcoming drug resistance by taking advantage of physical principles: Pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"12","author":"Nadiradze","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106160_bib5","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0128","article-title":"Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura and Peritoneum"},{"key":"10.1016\/j.humpath.2026.106160_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106160_bib7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/jcm12041289","article-title":"Response evaluation in patients with peritoneal metastasis treated with Pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)","volume":"12","author":"Roensholdt","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2026.106160_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.humpath.2026.106160_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/pp-2023-0014","article-title":"Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance","volume":"8","author":"Baake","year":"2023","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.humpath.2026.106160_bib10","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1245\/s10434-022-13010-0","article-title":"Treatment of peritoneal metastasis with pressurized intraperitoneal aerosol chemotherapy: results from the prospective PIPAC-OPC2 Study","volume":"30","author":"Graversen","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/his.13829","article-title":"Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis","volume":"74","author":"Solass","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106160_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.humpath.2021.12.005","article-title":"Role of immunohistochemistry for interobserver agreement of Peritoneal Regression Grading Score in peritoneal metastasis","volume":"120","author":"Detlefsen","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106160_bib13","article-title":"Prognostic value of baseline peritoneal fluid cytology in 224 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)","author":"J\u00f8rgensen","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106160_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/his.14092","article-title":"Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis","volume":"77","author":"Benzerdjeb","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106160_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1204886","article-title":"Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients","volume":"13","author":"Kefleyesus","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918777036","article-title":"Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis","volume":"10","author":"Graversen","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib17","article-title":"Real-world data on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed therapy in patients with peritoneal metastases","author":"J\u00f8rgensen","year":"2025103119","journal-title":"Third annual report from the ISSPP PIPAC database. Pleura Peritoneum"},{"key":"10.1016\/j.humpath.2026.106160_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejso.2019.08.024","article-title":"Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient","volume":"46","author":"Graversen","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib19","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases","volume":"28","author":"Tabchouri","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106160_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156250","article-title":"Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer","author":"Kulatheivam","year":"2025","journal-title":"Pathol Res Pract"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:28:41Z","timestamp":1786076921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0046817726001292"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106160","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of Combined Progression Index (CPI) in 132 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106160"}}